Starsource Multitrade

Starsource Multitrade P/TBV

Vrijednost Cena prema opipljivoj vrednosti knjige (P/TBV) od Starsource Multitrade (506365.BO) na dan 17. окт 2026. je 13,16. Prethodne godine, Cena prema opipljivoj vrednosti knjige (P/TBV) je bio 1,29 — promjena od 919,24% (viši).

P/TBV

13,16

YoY

919,24%

Zadnja ažuriranja:

Cena prema opipljivoj vrednosti knjige (P/TBV) od Starsource Multitrade je 2026 13,16 . Cena prema opipljivoj vrednosti knjige (P/TBV) od Starsource Multitrade je bio 2025 1,29 . Pad je time 919,24% viši u odnosu na prethodnu godinu.

Istorija Starsource Multitrade P/TBV

  • 3 године

  • 10 година

  • 25 godina

  • Максимално

P/TBV
Datum
P/TBV
1. јан 2019.
1,64 INR
1. јан 2020.
1,58 INR
1. јан 2021.
1,54 INR
1. јан 2022.
1,47 INR
1. јан 2023.
1,46 INR
1. јан 2024.
1,33 INR
1. јан 2025.
1,29 INR
1. јан 2026.
13,16 INR
Istorija Starsource Multitrade P/TBV
ГОДИНАP/TBVYoY
13,16+919,24%
1,29-2,60%
1,33-9,38%
1,46-0,41%
1,47-4,85%
1,54-2,27%
1,58-3,86%
1,64-2,00%
1,68-0,99%
1,69-63,35%
4,62+39,44%
3,31-5,29%
3,50—

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Starsource Multitrade Анализа акција

Šta radi Starsource Multitrade? Starsource Multitrade Ltd, identified by the ticker symbol 506365.BO and ISIN INE320M01019, is a corporate entity registered in India with its headquarters located in Mumbai, Maharashtra. The company was originally established through an initial public offering on January 2, 1995. While the specific sector and industry classifications are currently listed as not applicable, the company's operational history and strategic direction are closely tied to its former identity as Chemo Pharma Laboratories Ltd. This previous incarnation operated within the pharmaceutical industry, focusing on the development and distribution of healthcare products. However, the corporate landscape has shifted significantly, and the entity is no longer engaged in its original pharmaceutical activities. According to available information, the firm currently has no active operations within its traditional business lines. Instead, the organization is in a transitional phase, actively exploring new business opportunities to redefine its market presence. The strategic intent of the current management is to pivot away from pharmaceuticals and acquire businesses in the power and chemicals sectors. This move represents a substantial change in the company's core focus, aiming to diversify its portfolio and enter entirely different industrial segments. The company's official website, https://www.thechemopharmalaboratoriesltd.com/, reflects its historical branding, although the operational reality has evolved. Investors and stakeholders monitoring the company should note that the absence of current operations means that recent financial performance may not reflect traditional revenue streams associated with pharmaceutical manufacturing or sales. The focus is currently on strategic acquisitions and business development rather than organic growth from existing products. The transition from a pharmaceutical manufacturer to a holding or investment vehicle targeting power and chemical assets suggests a long-term restructuring plan. Until new acquisitions are finalized and integrated, the company remains in a state of exploration and preparation. The headquarters in Mumbai serves as the administrative center for these strategic discussions and future operational planning. The lack of a defined sector classification further underscores the company's current status as an entity in flux, waiting for new business units to be acquired and operationalized. This profile highlights the significant shift from its historical roots in healthcare to its current ambitions in energy and industrial chemicals, marking a distinct chapter in the company's corporate evolution. Starsource Multitrade je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji Starsource Multitrade

Cena prema opipljivoj vrednosti knjige (P/TBV) kompanije Starsource Multitrade iznosi 13,16 u 2026. godini.

Cena prema opipljivoj vrednosti knjige (P/TBV) od Starsource Multitrade se promijenio sa 1,29 na 13,16, što predstavlja promjenu od 919,24%. Vrijednost je viši nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj Cena prema opipljivoj vrednosti knjige (P/TBV) Starsource Multitrade od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

P/TBV poredi cenu akcije sa opipljivom vrednosti knjige po akciji, isključujući goodwill i nematerijalna sredstva. Pruža konzervativniju vrednost sredstava.

Da biste proverili Cena prema opipljivoj vrednosti knjige (P/TBV)'s, bitno je da ga uporedite sa konkurentima u istoj industriji i sektoru. Na Eulopoolu, možete pronaći direktna upoređivanja industrije za Cena prema opipljivoj vrednosti knjige (P/TBV).

Dobar varira u zavisnosti od industrije i faze razvoja preduzeća. Na Eulopoolu, možete porediti Cena prema opipljivoj vrednosti knjige (P/TBV)'s Starsource Multitrade sa sličnim preduzećima u sektoru i prosekom industrije da biste proverili da li je atraktivan.

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

Вредновање — Starsource Multitrade

Sve ključne metrike — Starsource Multitrade

Раст